로딩 중…
지수 로딩 중…
Optipharm.CO.,LTD
153710· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩4,575-2.35%
2026-06-19
Price Chart
Optipharm.CO.,LTD-6.06%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 67.12B KRW |
| Revenue | 22.79B KRW |
| Net Income | -343.3M KRW |
| Total Assets | 39.58B KRW |
| Net Assets | 24.76B KRW |
| Employees | 77 |
| Value | |
| P/B | 2.71x |
| P/S | 2.95x |
| EV/EBITDA | 725.52x |
| FCF Yield | -6.05% |
| Profitability | |
| ROE | -1.39% |
| ROA | -0.87% |
| Op. Margin | 0.39% |
| Revenue Growth | 9.01% |
| Financial Health | |
| Debt Ratio | 159.82% |
| Total Debt | 0 KRW |
| FCF | -4.06B KRW |
| Cash | 2.22B KRW |
| Current Ratio | 1.17x |
| Net Debt/EBITDA | -24.86x |
| Performance | |
| 1Y Return | -6.06% |
| 1M Return | -8.86% |
| From 52W High | -26.80% |
| 1Y MDD | -29.03% |
| Trading | |
| Volume | 5,057 shares |
| Foreign Own. | 1.13% |
| Per Share | |
| EPS | -144 KRW |
| BPS | 1,688 KRW |
Company Info
OptiPharm, established in 2000 and listed on KOSDAQ in 2018, specializes in animal-related businesses, including disease diagnosis, pharmaceuticals, and bacteriophage. Since 2006, it has developed an independent disease appraisal system and diagnostic products. Leveraging original technologies like transgenic technology and animal-related infrastructure, the company is expanding into human-related ventures such as bacteriophage-based disease treatments and xenotransplantation development.